 Connection
Alexis Ritvo to Benzodiazepines
This is a "connection" page, showing publications Alexis Ritvo has written about Benzodiazepines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.835 |
|
|
|
-
Horowitz M, Lamberson N, Brandt J, Framer A, Shapiro B, Sørensen A, Cadogan C, Ritvo A, Taylor D. Pharmacological principles for safe benzodiazepine and Z-drug dose reduction. Psychol Med. 2026 Jun 18; 56:e198.
Score: 0.219
-
Shade KN, Ritvo AD, Silvernail B, Finlayson AJR, Bressi JE, Foster DE, Martin IJ, Piper C, Martin PR. Long-term neurological consequences following benzodiazepine exposure: A scoping review. PLoS One. 2025; 20(8):e0330277.
Score: 0.207
-
Sigler B, Silvernail B, Ritvo AD, Huff C, Foster DE, Finlayson R, Bressi J, Martin PR. Evidence-Based Benzodiazepine Practice Guidelines Are Needed. J Clin Psychiatry. 2024 May 27; 85(2).
Score: 0.190
-
Ritvo AD, Foster DE, Huff C, Finlayson AJR, Silvernail B, Martin PR. Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLoS One. 2023; 18(6):e0285584.
Score: 0.178
-
Yager J, Ritvo AD, MacPhee ER. Psychiatrists' Cognitive and Affective Biases and the Practice of Psychopharmacology: Why Do Psychiatrists Differ From One Another in How They View and Prescribe Certain Medication Classes? J Nerv Ment Dis. 2022 10 01; 210(10):729-735.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|